发明授权
- 专利标题： Antisense modulation of cREL expression
- 专利标题（中）： cREL表达的反义调制
-
申请号： US156253申请日： 1998-09-18
-
公开(公告)号： US6001652A公开(公告)日： 1999-12-14
- 发明人: Brett P. Monia , Brenda F. Baker , Lex M. Cowsert
- 申请人： Brett P. Monia , Brenda F. Baker , Lex M. Cowsert
- 申请人地址： CA Carlsbad
- 专利权人： Isis Pharmaceuticals Inc.
- 当前专利权人： Isis Pharmaceuticals Inc.
- 当前专利权人地址： CA Carlsbad
- 主分类号： A61K38/00
- IPC分类号： A61K38/00 ; C12N15/113 ; C12N15/85 ; C07H21/04 ; C12N15/11 ; C12Q1/68
摘要：
Antisense compounds, compositions and methods are provided for modulating the expression of cREL. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding cREL. Methods of using these compounds for modulation of cREL expression and for treatment of diseases associated with expression of cREL are provided.
公开/授权文献
- US5459700A Manual timer control for inflation device 公开/授权日：1995-10-17
信息查询
IPC分类:
